Inverse neurovascular coupling in the hypothalamus and its role in positive feedback regulation of vasopressin neurons in health and disease - neurovascular coupling (NVC) links increases in…

Active Project Grant Awarded Last action

Award ID
R01HL162575
Recipient
Awarding agency
Obligated
$7,912,264

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 98% complete
Originally
Place of performance
Atlanta, GA 30303, USA

Award details come from USAspending.gov.

Description

Inverse neurovascular coupling in the hypothalamus and its role in positive feedback regulation of vasopressin neurons in health and disease - neurovascular coupling (NVC) links increases in neuronal activity with a rapid and spatially restricted increase in local blood flow. Knowledge on the cellular mechanisms driving NVC has been focused on transient exteroceptive sensory stimulation and limited to superficial dorsal brain areas (cortex). Thus, less is understood on NVC dynamics of deeper brain regions, which can be activated by slow, sustained, and widespread stimuli (e.g., physiological disturbances of bodily homeostasis). Derangement in homeostatic processes is a key driver of pathological mechanisms in prevalent diseases such as neurohumoral activation in heart failure (HF). To address this critical GAP in our knowledge, we developed a novel experimental approach that enables interoceptive-induced NVC during a challenge to bodily homeostasis. Our preliminary data show that contrary to the canonical NVC response, a systemic and physiological homeostatic challenge (acute salt-loading) progressively increased vasopressin (VP) neuronal firing, evoked activity-dependent vasoconstriction and decreased local blood flow in the hypothalamic supraoptic nucleus (SON). The salt-induced inverse NVC (invc) response was slow, sustained and widespread, and mediated by the dendritic release of VP within the SON. Invc resulted in local tissue hypoxia, which evoked further excitation of VP neurons. Based on these observations, we hypothesize that invc is a physiological process that contributes to positive feedback modulation of the VP neuronal population so that the physiological disturbance can be efficiently corrected. Still, the precise signaling mechanisms and cellular targets mediating this novel physiological modality of NVC, and more importantly, whether an aberrant invc response contributes to exacerbated VP neuronal activity characteristic of prevalent cardiometabolic diseases, such as HF, remains unknown. Using a multidisciplinary approach, in aim 1 we will elucidate the precise signaling mechanisms and cellular targets mediating activity- dependent invc in the SON (neuron-to-vessel signaling). In aim 2, we will determine the mechanisms and targets by which the invc evokes the positive feedback modulation of VP neuronal firing activity (vasculo-to- neuron signaling). Finally, in AIM3, we will elucidate mechanisms contributing to exacerbated invc-mediated positive feedback regulation of VP neurons in a disease state (HF). Both in vivo and EX vivo novel approaches (2-photon imaging, patch-clamp electrophysiology, and EX vivo cannulation of SON arterioles) will be used in novel transgenic RAT models that enable visualization (egfp) and manipulation (opto- and chemogenetically) of VP neurons in the SON. The activation of acid-sensing ION channels (asic) and modulation of astrocyte glutamate transporters will be investigated as key molecular targets. We expect results from this work to contribute to a better understanding of fundamental mechanisms underlying NVC responses in different brain regions and under different activity-dependent modalities. Moreover, we anticipate our studies to unveil novel pathological mechanisms and therapeutic targets for the treatment of highly prevalent cardiometabolic diseases. 1

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $67,194
Amendment $67,194
Amendment $67,194
Amendment $604,742
Amendment $604,742
Amendment $604,742
Amendment $53,755
Amendment $53,755
Amendment $604,742
Amendment $604,742
Amendment $604,742
Amendment $67,194
Amendment $67,194
Amendment $67,194
Amendment $67,194
Amendment $604,742
Amendment $604,742
Amendment $604,742
Amendment $604,742
Amendment $604,742
Amendment $0
Amendment $0
Amendment $0
Original award $682,234
Show all 27

Subawards

Subrecipient Amount Awarded
Augusta University Research Institute, Inc. Statement of Work Dr. Filosa's laboratory will contribute to the study by performing vascular reactivity experiments to be performed in an advanced brain… $232,795
Zentralinstitut FÜR Seelische Gesundheit Dr. Valery Grinevich will complete statistical work and will also produce and deliver viral vectors and RIA measurement of microdialysis VP on a yearly basis. $17,010
Augusta University Research Institute, Inc. Dr. Filosa's laboratory will contribute to the study by performing vascular reactivity experiments to be performed in an advanced brain slice preparation… $225,397
The University Of Central Florida Board Of Trustees TEACH ME - Scope of Work University of Central Florida Expecta􀆟ons The UCF team will be expected to par􀆟cipate in planning and training… $378,775

Quick answers

Who received award R01HL162575?

R01HL162575 was awarded to Georgia State University Research Foundation Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on December 1, 2021.

How much is award R01HL162575 worth?

$7,912,264 has been obligated on R01HL162575.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award